Follow
Maximilian A R Strobl
Maximilian A R Strobl
Postdoctoral Research Fellow, Cleveland Clinic, USA
Verified email at ccf.org - Homepage
Title
Cited by
Cited by
Year
Turnover modulates the need for a cost of resistance in adaptive therapy
MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ...
Cancer research 81 (4), 1135-1147, 2021
962021
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition
MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ...
Communications Medicine 2 (1), 1-18, 2022
492022
Look me in the eye: evaluating the accuracy of smartphone-based eye tracking for potential application in autism spectrum disorder research
MAR Strobl, F Lipsmeier, LR Demenescu, C Gossens, M Lindemann, ...
Biomedical engineering online 18 (1), 1-12, 2019
312019
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation
J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ...
Elife 12, e84263, 2023
242023
Immunosuppressive niche engineering at the onset of human colorectal cancer
CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ...
Nature Communications 13 (1), 1-16, 2022
242022
Mix and Match: Phenotypic Coexistence as a Key Facilitator of Cancer Invasion
MAR Strobl, AL Krause, M Damaghi, R Gillies, ARA Anderson, PK Maini
Bulletin of Mathematical Biology 82 (1), 1-26, 2020
202020
On simulated annealing phase transitions in phylogeny reconstruction
MAR Strobl, D Barker
Molecular phylogenetics and evolution 101, 46-55, 2016
202016
Combining radiomics and mathematical modeling to elucidate mechanisms of resistance to immune checkpoint blockade in non-small cell lung cancer
D Saeed-Vafa, R Bravo, JA Dean, A El-Kenawi, N Mon Père, M Strobl, ...
BioRxiv, 190561, 2017
132017
Antifragile therapy
J West, B Desai, M Strobl, L Pierik, R Vander Velde, C Armagost, R Miles, ...
bioRxiv, 2020.10. 08.331678, 2021
82021
Inter-and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics
J Gallaher, M Strobl, J West, R Gatenby, J Zhang, M Robertson-Tessi, ...
Cancer Research, CAN-22-2558, 2023
7*2023
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies
M Robertson-Tessi, JS Brown, M Poole, M Johnson, A Marusyk, ...
medRxiv, 2023.01. 18.23284628, 2023
62023
Drug dependence in cancer is exploitable by optimally constructed treatment holidays
J Maltas, ST Killarney, KR Singleton, MAR Strobl, R Washart, KC Wood, ...
Nature Ecology & Evolution 8 (1), 147-162, 2024
52024
Treatment of evolving cancers will require dynamic decision support
MAR Strobl, J Gallaher, M Robertson-Tessi, J West, ARA Anderson
Annals of Oncology 34 (10), 867-884, 2023
52023
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling
M Strobl, A Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ...
bioRxiv, 2023.03. 22.533721, 2023
52023
Harnessing patient-specific response dynamics to optimize evolutionary therapies for metastatic clear cell renal cell carcinoma-Learning to adapt
IC Sorribes, A Basu, R Brady, PM Enriquez-Navas, X Feng, JN Kather, ...
bioRxiv, 563130, 2019
32019
Connecting the Microenvironmental Niche to Treatment Response in Ovarian Cancer
M Strobl, M Wicker, V Adhikarla, WA Shockey, E Lakatos, P Pooladvand, ...
BioRxiv, 452052, 2018
12018
Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy
K Gallagher, MA Strobl, DS Park, FC Spoendlin, RA Gatenby, PK Maini, ...
Cancer Research, 2024
2024
Predicting progression in metastatic castrate-sensitive prostate cancer by coupling PSA and testosterone dynamics to a mechanistic mathematical model
J Gallaher, M Strobl, J West, M Robertson-Tessi, R Gatenby, J Zhang, ...
Cancer Research 83 (7_Supplement), 852-852, 2023
2023
Spatial transcriptomic driven mechanistic model to investigate and predict pathogenesis of oligodendroglioma
S Prabhakaran, H Cho, M Strobl, R Rockne, AR Anderson
Cancer Research 83 (7_Supplement), 6614-6614, 2023
2023
Applying the principles of convexity and concavity to guide treatment scheduling of ALK inhibitors in non-small cell lung cancer
J West, B Desai, M Strobl, L Pierik, RV Velde, M Robertson-Tessi, ...
Cancer Research 83 (7_Supplement), 847-847, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20